Journal
CELL METABOLISM
Volume 3, Issue 2, Pages 99-110Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2006.01.001
Keywords
-
Categories
Funding
- NHLBI NIH HHS [U01 HL70524] Funding Source: Medline
- NIDDK NIH HHS [2 R01 DK55033-06] Funding Source: Medline
Ask authors/readers for more resources
Forkhead transcription factor Foxa2 activates genes involved in hepatic lipid metabolism and is regulated by insulin. Activation of Foxa2 in the liver leads to increased oxidation and secretion of fatty acids in the form of triacylglycerols (TAGs), a process impaired in type 2 diabetes. Here, we demonstrate that Foxa2 is coactivated by PPAR gamma coactivator beta (Pgc-1 beta). Adenoviral expression of Foxa2 and Pgc-1 beta in livers of ob/ob mice results in decreased hepatic TAG content and increased plasma TAG concentrations. In addition, the concerted action of Foxa2/Pgc-1 beta activates genes in mitochondrial 0 oxidation and enhances fatty acid metabolism. Furthermore, Foxa2/Pgc-1 beta induce the expression of microsomal transfer protein, thereby increasing apoB-containing VLDL secretion. This process is inhibited by insulin through a Foxa2-dependent mechanism. These data demonstrate that Foxa2/Pgc-1 beta regulate hepatic lipid homeostasis by affecting the clearance rate of fatty acids through oxidation and/or secretion of lipids in response to insulin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available